Huons Global Co., Ltd.
Founded in 1987 and listed on KOSDAQ in 2006, Huons Global is the pure holding company of the Huons Group, with subsidiaries including Huons and Humedix.
As of 2026-10-10, Huons Global Co., Ltd. has 4 Korean MFDS device approvals, 3 Korean MFDS drug approvals on record (counted by the MAA Company Index from its own matching of public databases).
Price
Change
Market cap
Products & technology
- Lidocaine local anestheticLocal anesthetic injection (Huons)
- KainixHyaluronic acid eye drops (Huons)
- Merit seriesHigh-dose vitamin injections and health supplements (Huons)
- InnersetIn-house health supplement brand (Huons N)
- Hyaluronic acid fillers and arthritis treatmentsFillers and arthritis treatment products (Humedix)
- Biosimilar EPO drugBiosimilar drug production/sale and CDMO services (Pangen)
Regulatory approvals
data.go.kr3 Korean MFDS drug approvals · 2016–2021 / 4 Korean MFDS device approvals · 2014–2026
- MFDSSubsidiary: ㈜휴엠앤씨Injector, medication/vaccine, hyaline2026-05-21Product approval · Class 1수신 26-1104 호
- MFDSSubsidiary: ㈜휴엠앤씨Injector, medication/vaccine, hyaline2022-05-20Product approval · Class 1수신 22-901 호
- MFDS drugSubsidiary: ㈜휴온스바이오파마LIZTOX Inj. 200Unit2021-07-09Drug · Prescription · Approval202105225
- MFDS drugSubsidiary: ㈜휴온스바이오파마LIZTOX Inj. 50Unit2021-06-15Drug · Prescription · Approval202104572
- MFDSSubsidiary: ㈜휴엠앤씨Direct infusion deviceRevoked2021-04-30Product approval · Class 2수인 21-4198 호
- MFDS drugSubsidiary: ㈜휴온스바이오파마LIZTOX Inj. 100Unit2016-10-10Drug · Prescription · Approval201605990
- MFDSSubsidiary: ㈜휴엠앤씨Injector, medication/vaccine, hyaline2014-01-17Product approval · Class 1대전 수신 14-3 호
Clinical trials
data.go.kr2 MFDS clinical trial authorisations · 2017–2018 (Phase 1/3 1 · Phase 3 1)
- Phase 1/3리즈톡스주100단위(클로스트리디움보툴리눔독소A형)2018-08-10
2 trial sites
- Phase 3리즈톡스주100단위(클로스트리디움보툴리눔독소A형)2017-10-18
3 trial sites
Global clinical trials
ClinicalTrials.gov · sponsor-matched- Subsidiary: ㈜휴온스바이오파마To Evaluate HU-045 in the Treatment of Glabellar Lines(Phase III)
Phase 3 · Recruiting · 2024-06 · NCT06205797
- Subsidiary: ㈜휴온스바이오파마To Evaluate the Efficacy and Safety of LIZTOX in Subjects with Benign Masseteric Hypertrophy
Phase 3 · Unknown · 2023-07 · NCT05964257
Key disclosures
KRX KIND via OpenDARTPatents
KIPRIS · applicant-matched- Subsidiary: ㈜휴온스바이오파마BOTULINUM TOXIN-STABILIZING LIQUID COMPOSITION
CN · Published · 2019-11 · Application 201980079156.4
- Subsidiary: ㈜휴온스바이오파마BOTULINUM TOXIN-STABILIZING LIQUID COMPOSITION
US · Published · 2019-11 · Application 17298386
- Subsidiary: ㈜휴온스바이오파마BOTULINUM TOXIN-STABILIZING LIQUID COMPOSITION
EP · Published · 2019-11 · Application 19891569.6
PCT · Published · 2019-11 · Application PCT/KR2019/016669
Registered · 2015-06 · Application 1020150078538
Expired · 2014-11 · Application 1020140151114
Registered · 2014-10 · Application 1020140141089
Registered · 2013-01 · Application 1020130007699
Registered · 2011-10 · Application 1020110111484
Registered · 2008-04 · Application 1020080034907
Show 16 more patents
Expired · 2007-07 · Application 1020070074311
Rejected · 2007-04 · Application 2020070006712
Expired · 2007-04 · Application 2020070006713
Withdrawn · 2007-02 · Application 1020070019080
Withdrawn · 2005-11 · Application 1020050106480
Expired · 2002-12 · Application 2020020036890
Withdrawn · 2002-12 · Application 1020020078428
Expired · 2000-07 · Application 2020000019297
Expired · 2000-07 · Application 2020000019300
Rejected · 2000-07 · Application 1020000038456
Expired · 2000-07 · Application 1020000038490
Expired · 2000-06 · Application 1020000036291
Expired · 2000-06 · Application 1020000036307
Expired · 1999-04 · Application 1019990015438
Expired · 1998-04 · Application 1019980013979
Expired · 1998-04 · Application 1019980013980
AI reads
MAA server logs · IP-verifiedPulled records become part of each AI's index and keep feeding its answers. When an AI cites from that index, nothing reaches our server — so actual citations are uncounted here and exceed this number.
Times an AI needed something not yet in its index and fetched this page fresh while answering. Citations served from the index leave no trace here.
Collected as raw material for future answers.
Queries from users who connected this index to their own AI.
- OpenAIOAI-SearchBot4
- GoogleGoogleOther2
- PerplexityPerplexityBot2
- AnthropicClaudeBot2
- MicrosoftBingbot1
Measured since Aug 27, 2026 · 5 AI engines · last read Oct 1, 2026
User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS. MCP queries are actual calls to this index's tool endpoint.
Connect this company index directly to your AI
Connect it to ChatGPT or Claude, and your AI queries the full record — profiles, financials, stock data, regulatory approvals, clinical trials, publications and patents — for Huons Global Co., Ltd. and every listed Korean medical, bio and AI company.
How to connect (MCP)Companies approved for the same productsPharma & CDMO
Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.
KOSDAQ-listed aesthetic medical device company producing PICO, DUAL HI, and other anti-aging and body-contouring devices.
KOSDAQ-listed medical device maker producing disposable acupuncture needles, cupping cups, and hyaluronic acid dermal fillers.
Founded in 1941 and listed on the KOSPI in 1975, Ildong Holdings is the holding company of the Ildong Pharmaceutical Group, overseeing pharmaceutical, aesthetic medical device, and drug development affiliates.
Founded in 1941 and listed on the KOSPI in 1975, Yuyu Pharma is a pharmaceutical company with a co-promotion agreement with Dong-A ST for Tanamin.
Founded and listed on the KOSPI in 2016, Il Dong Pharmaceutical manufactures products including the Aronamin vitamin line.
Founded 2000, KOSDAQ-listed 2009, Medy-Tox develops and exports botulinum toxin biopharmaceuticals including Meditoxin and Innotox.
KOSPI-listed comprehensive pharmaceutical company specializing in blood products and vaccines, with FDA-approved immunoglobulin ALYGLO.
KOSPI-listed pharmaceutical company behind Coldwon cold medicine and Jangdaewon probiotics, developing a P-CAB drug pipeline.
Founded 2011, listed 2016 — Samsung Biologics is a biopharma CDMO with 785,000L capacity across five Songdo plants.
Founded in 2006 and listed on KOSDAQ in 2020, Genolution is a molecular diagnostics and RNAi company producing nucleic acid extraction reagents and devices.
Ahn-Gook Pharmaceutical sells the cough/expectorant drug Sinecuran and the eye-health supplement Tobicom.
Founded in 2003 and listed on KOSDAQ in 2015, Corestem Chemon develops stem cell therapies and provides nonclinical CRO services, including the ALS treatment Neuronata-R.
Sources and updates
Counts on this page are not company-reported figures. MAA matched records from DART, the Korean MFDS, the US FDA, ClinicalTrials.gov, PubMed and KIPRIS to this company itself, by business registration number or registered name, never by name similarity. They may differ from figures the company publishes.
- Company basics
- Korea Exchange · DART
- Business content
- Compiled from disclosure filings
- Approvals & clinical trials
- Korean MFDS (data.go.kr) · US FDA openFDA — updated weekly
- Key disclosures
- KRX KIND via OpenDART exchange filings — updated daily
- Global clinical trials
- ClinicalTrials.gov (US NIH) — sponsor-matched, updated weekly
- Financials
- DART corporate disclosure filings — annual
- Publications
- PubMed (US National Library of Medicine) — affiliation-matched, updated daily
- Patents
- KIPRIS (Korea Institute of Patent Information) — applicant-matched, updated monthly
- AI reads
- Our server logs, IP-verified every 6 hours
- AI visibility
- Measured 2026-10-01
This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.
Request a correction or addition